Clinical Trials in Pittsburgh

Showing 19701-19720 of 21,047 trials

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

NCT00772928

This study is designed to evaluate in a controlled manner the effect of Prevnar® on the immune responses of Pentacel™ Primary Objective - Stage I: To compare the immune responses elicited by an infant series of Pentacel™ when given at different times from or concurrently with a Pneumococcal conjugate vaccine (Prevnar®). Primary Objective - Stage II: To compare the immune responses elicited by a 4th dose of Pentacel™ when given at different times from or concurrently with Prevnar®.

DiphtheriaTetanusHaemophilus Infection+2 more

Sanofi1,167 participantsStarted Oct 2003

Montgomery, Alabama, United States • Fayetteville, Arkansas, United States • Jonesboro, Arkansas, United States +20 more locations

COMPLETEDPhase 2< 1 mile

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

NCT00501735

This is a Phase II, non-randomized, open-label, single-arm trial that will be conducted at up to 50 sites in North America, Europe and Australia. This study is designed to assess objective response (OR) \[complete response (CR) or partial response (PR)\] in subjects with cutaneous manifestations of CTCL with a requirement for maintenance of such objective response for at least 28 days in subjects with stage IIB, III, and IVA CTCL. Additionally, this study will evaluate the safety and tolerability of CTCL subjects Stages IB, IIA, IIB, III, or IVA treated with oral forodesine.

Cutaneous T-cell Lymphoma (CTCL),

BioCryst Pharmaceuticals144 participantsStarted Jul 2007

Birmingham, Alabama, United States • Stanford, California, United States • New Haven, Connecticut, United States +38 more locations

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Find Trials by Condition in Pittsburgh

The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Extraction of Stromal Vascular Fraction and Stem Cells From Fat Tissue

NINDS CRC Chronic Migraine Treatment Trial

Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

Feasibility Study of a New Fistula Pouching System

Concomitant Treatment of Permanent Atrial Fibrillation

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Safety/Efficacy Study of Restylane® in Lip Augmentation

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Weight Management Demonstration Project: HEALTH

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia